A novel mutation of SETBP1 in atypical chronic myeloid leukemia transformed from acute myelomonocytic leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-0904|3|6|448-452

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.3, Iss.6, 2015-06, pp. : 448-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MLL‐ELL fusion gene in an acute myelomonocytic leukemia patient transformed from acute promyelocytic leukemia

By  

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 402-405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dasatinib: In Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

By Keam Susan J.  

BioDrugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 59-69

Adis International

Access to resources Recommend Favorite

Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia†

By McCormack Paul L.   Keam Susan J.  

BioDrugs, Vol. 26, Iss. 1, 2012-02 ,pp. : 61-64

Adis International

Access to resources Recommend Favorite

Spotlight on Imatinib Mesylate in Chronic Myeloid Leukemia

By Curran M.P.   Croom K.F.   Goa K.L.  

BioDrugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

By Mosna Federico   Capelli Debora   Gottardi Michele  

Journal of Clinical Medicine, Vol. 6, Iss. 6, 2017-06 ,pp. : 57-57

MDPI

Access to resources Recommend Favorite